Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of July 15, 2026, SPRO trades at $1.64 with a market cap of $126.23M and a P/E ratio of 6.53. SPRO moved -22.25% today. Year to date, SPRO is -27.04%; over the trailing twelve months it is -35.61%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SPRO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.64 |
| Market Cap | $126.23M |
| P/E Ratio | 6.53 |
| EPS | $0.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.22 |
| 52-Week Low | $0.51 |
| Volume | 10.23M |
| Avg Volume | 0 |
| Revenue (TTM) | $61.19M |
| Net Income | $15.23M |
| Gross Margin | 0.00% |
SPRO analyst coverage data. Average price target: $0.00.